KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$4.6 million.

  • LifeMD's Net Income towards Common Stockholders rose 1567.41% to -$4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 4568.68%. This contributed to the annual value of -$24.5 million for FY2024, which is 343.02% down from last year.
  • LifeMD's Net Income towards Common Stockholders amounted to -$4.6 million in Q3 2025, which was up 1567.41% from -$2.4 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Net Income towards Common Stockholders ranged from a high of -$960341.0 in Q1 2025 and a low of -$19.0 million during Q4 2021
  • Its 5-year average for Net Income towards Common Stockholders is -$8.9 million, with a median of -$7.5 million in 2024.
  • In the last 5 years, LifeMD's Net Income towards Common Stockholders crashed by 39808.0% in 2021 and then surged by 8727.17% in 2025.
  • Over the past 5 years, LifeMD's Net Income towards Common Stockholders (Quarter) stood at -$19.0 million in 2021, then surged by 33.03% to -$12.7 million in 2022, then skyrocketed by 64.53% to -$4.5 million in 2023, then fell by 26.76% to -$5.7 million in 2024, then grew by 19.82% to -$4.6 million in 2025.
  • Its Net Income towards Common Stockholders was -$4.6 million in Q3 2025, compared to -$2.4 million in Q2 2025 and -$960341.0 in Q1 2025.